+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fluorescence in Medical Device Market by Technology (Fluorescence Imaging Systems, Fluorescence Spectroscopy, Fluorescent Dyes & Agents), Fluorophore Type (Endogenous Fluorophores, Exogenous Fluorophores), Application, End-User - Global Forecast 2025-2030- Product Image
Fluorescence in Medical Device Market by Technology (Fluorescence Imaging Systems, Fluorescence Spectroscopy, Fluorescent Dyes & Agents), Fluorophore Type (Endogenous Fluorophores, Exogenous Fluorophores), Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Fluorescence in Medical Device Market by Technology (Fluorescence Imaging Systems, Fluorescence Spectroscopy, Fluorescent Dyes & Agents), Fluorophore Type (Endogenous Fluorophores, Exogenous Fluorophores), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6160131
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fluorescence in Medical Device Market grew from USD 4.81 billion in 2024 to USD 5.25 billion in 2025. It is expected to continue growing at a CAGR of 9.45%, reaching USD 8.28 billion by 2030.

Introducing Fluorescence’s Impact on Modern Medical Devices

Fluorescence technology is reshaping the medical device landscape by enabling unprecedented precision in imaging, diagnostics, and therapeutic interventions. From illuminating cellular structures to guiding surgeons in real time, fluorescence applications have advanced from experimental concepts to critical tools in patient care. Recent breakthroughs in fluorophore chemistry and high-sensitivity detectors now allow clinicians to visualize biological processes with clarity and confidence, driving enhanced outcomes across surgical and diagnostic environments.

This executive summary synthesizes key trends, challenges, and opportunities in the fluorescence medical device sector. It highlights transformative shifts in technology integration and regulatory frameworks, examines the impact of United States tariff changes slated for 2025, and presents segmentation insights that reveal where innovation and investment intersect. Additionally, regional dynamics and competitive intelligence offer a holistic view of market forces shaping the adoption of fluorescence solutions globally. Industry leaders, investors, and decision-makers will find in these pages a concise yet comprehensive narrative that guides strategic planning and resource allocation in an era defined by rapid technological evolution.

Pioneering Transformations Redefining Fluorescence Applications

The fluorescence medical device landscape is undergoing a profound transformation driven by advances in imaging hardware, fluorophore design, and data analytics. Integration of artificial intelligence with fluorescence imaging systems has elevated diagnostic accuracy, enabling automated detection of pathological signals and reducing clinician workload. Concurrently, innovations in spectroscopy platforms have improved sensitivity and specificity, unlocking new applications in real-time tissue characterization and minimally invasive interventions.

Chemists continue to develop novel fluorescent dyes and agents with tunable emission spectra and enhanced biocompatibility, expanding the toolbox available for targeted imaging and therapeutic monitoring. These developments coincide with shifting regulatory paradigms that emphasize patient safety, standardized reporting, and accelerated approval pathways for fluorescence-guided surgery tools. As surgical suites adopt connected devices and cloud-based analytics, the convergence of fluorescence technology with digital health ecosystems is catalyzing collaborative workflows and data-driven decision-making.

United States Tariff Adjustments Shaping the 2025 Landscape

The introduction of updated United States tariffs in 2025 will reverberate across the fluorescence medical device supply chain, affecting raw materials, component sourcing, and finished product pricing. Devices dependent on specialized optical filters and high-performance detectors may face increased import costs, prompting manufacturers to evaluate alternative suppliers or to reshore production. These tariff adjustments necessitate a strategic reassessment of procurement models to mitigate cost inflation and ensure uninterrupted delivery of critical imaging and diagnostic equipment to healthcare providers.

Beyond direct cost implications, tariff-driven shifts will influence global trade flows, compelling companies to diversify manufacturing footprints in the Americas, Europe, and Asia. Strategic partnerships with regional producers can alleviate exposure to punitive duties, while joint ventures may facilitate shared R&D investments and regulatory harmonization. As market participants navigate this evolving policy environment, proactive supply chain resilience planning will become an essential competency for sustaining competitive advantage in the fluorescence device sector.

Insights from Core Market Segmentation Dimensions

A nuanced understanding of market segmentation reveals where growth prospects and innovation hotspots are most concentrated. When analyzed by technology, fluorescence imaging systems continue to attract the lion’s share of R&D spending, as their applications in surgical guidance and diagnostics expand. Fluorescence spectroscopy is gaining traction for quantitative tissue analysis, while fluorescent dyes and agents benefit from breakthroughs in molecular targeting and clearance profiles.

Examining fluorophore type shows that endogenous markers pave the way for non-invasive metabolic monitoring, yet exogenous compounds lead in targeted imaging applications that demand high signal-to-noise ratios. In application segments, catheter-based fluorescence detection is emerging as a valuable tool in interventional cardiology, while fluorescence-guided surgery spans cardiovascular procedures, neurosurgical navigation, oncology resections, and orthopedic interventions. Endoscopic fluorescence imaging is driving progress in gastrointestinal diagnostics, whereas laboratory techniques like fluorescence microscopy and fluorescence-based ophthalmic imaging remain indispensable for research and clinical pathology. In vivo fluorescence imaging platforms are also expanding, enabling longitudinal studies and preclinical drug evaluation.

End-user analysis underscores that diagnostic laboratories continue to adopt fluorescence platforms for high-throughput assays, hospitals and clinics integrate these systems into operating suites, and research and academic institutes forge novel applications through early-stage collaborations.

Regional Dynamics Driving Global Fluorescence Adoption

Regional performance in the fluorescence medical device market varies significantly based on healthcare infrastructure, regulatory agility, and research intensity. In the Americas, robust reimbursement mechanisms and a concentration of leading medical device manufacturers drive rapid adoption of advanced fluorescence systems. The presence of major diagnostic laboratories and top-tier academic research centers fuels demand for both clinical and preclinical applications.

Europe, the Middle East, and Africa collectively benefit from harmonized regulatory standards and extensive clinical trial networks, facilitating the rollout of fluorescence-guided surgery solutions and endoscopic imaging platforms across diverse healthcare settings. Established healthcare systems in Western Europe and emerging markets in the Middle East and Africa present complementary growth trajectories.

Asia-Pacific markets are characterized by accelerating investment in precision medicine infrastructure and a growing emphasis on cost-effective diagnostic tools. Rapidly expanding hospital chains in East and Southeast Asia are integrating fluorescence technologies to differentiate service offerings, while research institutes in Japan and Australia drive innovations in fluorophore chemistry and imaging modalities.

Competitive Pulse: Key Players Shaping the Market

Competitive differentiation in the fluorescence medical device sector hinges on integrated hardware-software offerings, strategic alliances, and a robust product pipeline. Leading instrumentation firms leverage their expertise in optical engineering to deliver turnkey imaging systems that combine high-resolution detectors with AI-driven analytics. Meanwhile, specialty dye manufacturers focus on proprietary fluorophore libraries that offer enhanced photostability and targeted binding characteristics.

Partnerships between device developers and pharmaceutical companies are accelerating the clinical validation of fluorescence agents in surgical oncology and vascular interventions. Concurrently, major life science tools providers are integrating spectroscopy modules into existing microscopy and diagnostic platforms, broadening their footprint in translational research and clinical laboratories. Emerging players are carving niches in compact, point-of-care fluorescence devices designed for decentralized testing and intraoperative applications, challenging incumbents to adapt their strategies to an increasingly fragmented market.

Strategic Imperatives for Industry Advancement

Industry leaders should prioritize aligning R&D investments with evolving clinical needs and regulatory expectations. By forging cross-sector collaborations that unite imaging experts with surgical teams and academic researchers, organizations can accelerate the translation of novel fluorophores and detection technologies into practice. Implementing flexible manufacturing strategies-such as dual-sourcing optical components and establishing regional production hubs-will mitigate tariff risks and strengthen supply chain resilience.

Adopting platform-based product architectures that support modular upgrades ensures long-term customer retention and creates opportunities for recurring revenue through software enhancements and agent consumables. Leaders must also engage proactively with policymakers to advocate for balanced tariff policies and streamlined approval pathways. Finally, cultivating specialized talent in photonics, data science, and regulatory affairs will underpin sustainable innovation and competitive differentiation in the fluorescence device space.

Robust Methodology Underpinning Our Analysis

This analysis integrates a rigorous research framework combining secondary data from peer-reviewed journals, industry white papers, and regulatory filings with insights derived from primary interviews conducted with key opinion leaders, device manufacturers, and healthcare practitioners. Each segmentation dimension was validated through cross-referencing historical adoption patterns, patent filings, and clinical trial registries. Regional market dynamics were assessed by synthesizing public reimbursement data, hospital infrastructure reports, and trade statistics.

Quantitative findings were triangulated with qualitative feedback obtained through expert workshops and in-depth stakeholder consultations. To ensure accuracy and objectivity, multiple rounds of data verification were performed, incorporating input from independent domain specialists. While every effort has been made to present a comprehensive view of the fluorescence medical device market, limitations inherent in forecast assumptions and reporting lag were carefully considered to maintain analytical integrity.

Concluding Perspectives on Fluorescence Innovation

Fluorescence technology stands at the cusp of redefining diagnostic and therapeutic paradigms in medicine. The convergence of advanced imaging systems, tailored fluorophores, and AI-driven analytics creates fertile ground for continued innovation. Yet, stakeholders must remain vigilant in addressing supply chain vulnerabilities and policy uncertainties, particularly those stemming from evolving tariff regimes.

As market participants navigate complex segmentation landscapes-from technology platforms and fluorophore classes to clinical applications and end-user contexts-catapulting growth will depend on strategic collaboration and agile execution. Regional disparities in regulatory environments and healthcare infrastructure present both challenges and opportunities, underscoring the importance of tailored market entry and expansion strategies. By embracing a proactive stance toward regulatory engagement, manufacturing flexibility, and strategic partnerships, industry leaders can harness the full potential of fluorescence-driven medical advancements.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Fluorescence Imaging Systems
    • Fluorescence Spectroscopy
    • Fluorescent Dyes & Agents
  • Fluorophore Type
    • Endogenous Fluorophores
    • Exogenous Fluorophores
  • Application
    • Fluorescence in Catheters
    • Fluorescence-Guided Surgery
      • Cardiovascular Surgery
      • Neurosurgery
      • Oncology Surgery
      • Orthopedic Surgery
    • Imaging & Diagnostics
      • Endoscopic Fluorescence Imaging
      • Fluorescence Microscopy
      • Fluorescence-Based Ophthalmic Imaging
      • In Vivo Fluorescence Imaging
    • Therapeutic
  • End-User
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Research & Academic Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • ADVACAM s.r.o.
  • Arthrex, Inc.
  • Bruker Corporation
  • Carl Zeiss AG.
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • KARL STORZ SE & Co. KG
  • Leica Microsystems GmbH
  • LI-COR Biotech, LLC
  • Mauna Kea Technologies
  • Medtronic International Trading Sárl
  • MolecuLight Inc.
  • Olympus Corporation of the Americas
  • OnLume Inc.
  • Optomedic.
  • PerkinElmer U.S. LLC
  • PicoQuant GmbH
  • Shimadzu Corporation
  • Stryker Corporation
  • Xuzhou Hengjia Electronic Technology Co., Ltd.
  • SurgiMab SAS

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Illuminating the Rise of Fluorescence in Medical Diagnostics
3.2. Decoding Consumer Drivers and Competitive Forces in Fluorescence Devices
3.3. Strategic IP Positioning and Lifecycle Stages of Fluorescence Technologies
3.4. Charting Growth Paths and Emerging Trends in Fluorescence Applications
4. Market Overview
4.1. Introduction
4.1.1. Illuminating Fluorescence Applications Driving Healthcare Innovation
4.1.2. Regional Dynamics Shaping Fluorescence Adoption in Medical Devices
4.1.3. Recent Advancements and Strategic Moves in Fluorescence Technologies
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of near-infrared fluorescence probes for deeper tissue imaging in oncology applications
5.1.1. Unveiling the Expansion of Near-Infrared Fluorescence Probes for Deeper Oncology Imaging
5.1.2. Disruption in Fluorescence Medical Devices Driven by Advanced Near-Infrared Probes
5.1.3. Navigating the Next 5 Years of Near-Infrared Probe Expansion in Oncology Devices
5.2. Integration of near-infrared fluorescence imaging with robotic surgery systems to enhance tumor visualization
5.2.1. Illuminating Tumors with Near-Infrared Fluorescence and Robotics
5.2.2. Transforming Surgical Oncology through Integrated Fluorescence Robotics
5.2.3. Future Pathways and Risks for Robotic NIR Fluorescence Integration
5.3. Adoption of AI-powered fluorescence analysis software for enhanced tissue differentiation
5.3.1. Deep Dive into AI-Powered Fluorescence Tissue Differentiation
5.3.2. Transforming the Fluorescence Device Ecosystem with AI Analysis
5.3.3. Navigating the Future of AI-Driven Fluorescence Tissue Imaging
5.4. Emergence of wearable fluorescence biosensors for continuous monitoring of metabolic biomarkers
5.4.1. Wearable Fluorescence Biosensors: Key Characteristics and Drivers
5.4.2. Shifting Paradigms in Fluorescence Device Markets Through Continuous Monitoring
5.4.3. Future Pathways and Strategic Imperatives for Fluorescent Wearables
5.5. Collaborations between hospitals and biotech firms to commercialize novel fluorescent contrast agents
5.5.1. Defining Hospital-Biotech Alliances for Fluorescent Contrast Agents
5.5.2. How Collaborative Partnerships Are Redefining the Fluorescence Device Ecosystem
5.5.3. Navigating the Future of Hospital-Biotech Collaborations in Fluorescence Imaging
5.6. Advances in real-time intraoperative fluorescence-guided tumor margin detection tools for oncology
5.6.1. Illuminating Precision: Understanding Real-Time Intraoperative Fluorescence-Guided Tumor Margin Detection Tools
5.6.2. Reshaping Oncology Devices: How Fluorescence-Guided Margin Detection Drives Innovation and Competitive Advantage
5.6.3. Charting the Future: Trajectories, Risks, and Strategic Responses for Fluorescence-Guided Tumor Margin Technologies
5.7. Development of dual-modality clinical imaging platforms combining fluorescence and ultrasound modalities
5.7.1. Integrating Fluorescence and Ultrasound for Enhanced Clinical Imaging
5.7.2. Transformative Impact on Market Dynamics and Innovation Pathways
5.7.3. Navigating the Future: Evolution, Challenges, and Strategic Pathways
5.8. Growth of handheld fluorescence imaging devices for vascular mapping and dermatological assessments
5.8.1. Defining the Surge of Portable Fluorescence Imaging in Vascular and Skin Diagnostics
5.8.2. Shifting Paradigms: How Handheld Fluorescence Tools Redefine Market Dynamics and Spur Innovation
5.8.3. Navigating Tomorrow’s Path: Forecasting and Mitigating Risks for Handheld Fluorescence Imaging Growth
5.9. Regulatory harmonization and standardization efforts driving global commercialization of fluorescence medical devices
5.9.1. Defining Global Regulatory Harmony in Fluorescence Medical Devices
5.9.2. How Standardization is Reshaping the Fluorescence Device Market
5.9.3. Navigating the Future of Harmonized Regulation in Fluorescence Medicine
5.10. Rising demand for three-dimensional fluorescence microscopy in minimally invasive diagnostic procedures
5.10.1. Emergence of 3D Fluorescence Imaging in Minimally Invasive Diagnostics
5.10.2. Transformational Impact on Medical Imaging Ecosystems
5.10.3. Navigating the Future of 3D Fluorescence in Medical Diagnostics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Steep Entry Barriers Shield Fluorescence Device Market
6.1.2. Substitution Threats Emerge from Alternative Imaging Methods
6.1.3. Supplier Leverage in Fluorescent Component Sourcing
6.1.4. Buyer Negotiation Shapes Fluorescence Device Pricing Dynamics
6.1.5. Innovation-Driven Rivalry Intensifies Market Competition
6.2. PESTLE Analysis
6.2.1. Shifting Regulatory Landscapes Drive Innovation Pathways
6.2.2. Economic Currents Shaping Fluorescence Device Viability
6.2.3. Demographic Shifts Fuel Demand for Fluorescent Imaging
6.2.4. Frontiers of Fluorescent Imaging Technology Evolution
6.2.5. Legal Guardrails Steering Fluorescent Device Development
6.2.6. Environmental Imperatives and Sustainability in Device Design
7. Cumulative Impact of United States Tariffs 2025
7.1. Notable Tariffs Reshaping the U.S. Market
7.2. Tracing the Evolution of American Tariff Policy
7.3. How Tariffs Have Fueled Global Price Pressures
7.4. Unpacking Retaliatory Duties and Trade Battles
7.5. Toll on Key Partners: Economic and Political Repercussions
7.6. Tariffs as a Catalyst for Supply Chain Overhaul
7.7. Charting a Course: Policy Remedies to Soften Tariff Strains
8. Fluorescence in Medical Device Market, by Technology
8.1. Introduction
8.2. Fluorescence Imaging Systems
8.3. Fluorescence Spectroscopy
8.4. Fluorescent Dyes & Agents
9. Fluorescence in Medical Device Market, by Fluorophore Type
9.1. Introduction
9.2. Endogenous Fluorophores
9.3. Exogenous Fluorophores
10. Fluorescence in Medical Device Market, by Application
10.1. Introduction
10.2. Fluorescence in Catheters
10.3. Fluorescence-Guided Surgery
10.3.1. Cardiovascular Surgery
10.3.2. Neurosurgery
10.3.3. Oncology Surgery
10.3.4. Orthopedic Surgery
10.4. Imaging & Diagnostics
10.4.1. Endoscopic Fluorescence Imaging
10.4.2. Fluorescence Microscopy
10.4.3. Fluorescence-Based Ophthalmic Imaging
10.4.4. In Vivo Fluorescence Imaging
10.5. Therapeutic
11. Fluorescence in Medical Device Market, by End-User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals & Clinics
11.4. Research & Academic Institutes
12. Americas Fluorescence in Medical Device Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Fluorescence in Medical Device Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Fluorescence in Medical Device Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. ADVACAM s.r.o.
15.3.1.1. Emergence and Evolution of a Fluorescence Imaging Pioneer
15.3.1.2. Illuminating Pathology with Cutting-Edge Fluorescence Solutions
15.3.1.3. Navigating Challenges through Innovation and Strategic Partnerships
15.3.2. Arthrex, Inc.
15.3.2.1. Arthrex’s Evolution into Fluorescence-Driven Medical Devices
15.3.2.2. Flagship Fluorescence Solutions Driving Surgical Precision
15.3.2.3. Navigating Risks and Strategic Imperatives for Growth
15.3.3. Bruker Corporation
15.3.3.1. Tracing Bruker’s Rise in Fluorescence for Medical Devices
15.3.3.2. Inside Bruker’s Flagship Fluorescence Solutions and Their Clinical Impact
15.3.3.3. Navigating Threats and Strategizing Growth in Medical Fluorescence
15.3.4. Carl Zeiss AG.
15.3.4.1. Deep Dive into Carl Zeiss AG’s Fluorescence Device Portfolio
15.3.4.2. Navigating Risks and Fortifying Future Fluorescence Innovations
15.3.5. Getinge AB
15.3.5.1. Getinge AB’s Evolution and Emergence in Fluorescence-Enabled Medical Devices
15.3.5.2. Key Fluorescence-Integrated Offerings Driving Clinical Adoption and Impact
15.3.5.3. Navigating Risks and Strategic Levers for Fluorescence Market Leadership
15.3.6. Hamamatsu Photonics K.K.
15.3.6.1. Hamamatsu Photonics’ Evolution and Strategic Footprint in Fluorescence Medical Devices
15.3.6.2. Evaluating Core Fluorescence Products: Features, Performance, and Market Relevance
15.3.6.3. Mitigating Risks and Strengthening Market Leadership in Fluorescence Medical Technology
15.3.7. KARL STORZ SE & Co. KG
15.3.7.1. Illuminating a Legacy: Karl Storz’s Ascent in Fluorescence-Guided Surgery
15.3.7.2. Fluorescence Unveiled: Evaluating Karl Storz’s Flagship Imaging Solutions
15.3.7.3. Navigating Hazards and Harnessing Growth: Strategic Imperatives for Karl Storz
15.3.8. Leica Microsystems GmbH
15.3.8.1. A Legacy Illuminated: Leica Microsystems in Fluorescence Medical Imaging
15.3.8.2. Flagship Fluorescence Platforms Powering Modern Medical Diagnostics
15.3.8.3. Navigating Risks and Charting Strategic Growth Paths in Fluorescence Devices
15.3.9. LI-COR Biotech, LLC
15.3.9.1. LI-COR Biotech’s Legacy and Global Footprint in Fluorescence Diagnostics
15.3.9.2. Flagship Fluorescence Platforms Delivering Quantitative Precision for Medical Research
15.3.9.3. Addressing Regulatory, Competitive, and Supply Chain Risks with Strategic Initiatives
15.3.10. Mauna Kea Technologies
15.3.10.1. From Lab to Clinic: Mauna Kea’s Rise in Fluorescence Imaging
15.3.10.2. Cellvizio Unveiled: Aligning Confocal Imaging with Clinical Needs
15.3.10.3. Navigating Hazards: Securing Mauna Kea’s Growth in Fluorescent Diagnostics
15.3.11. Medtronic International Trading Sárl
15.3.11.1. Innovative Fluorescence Imaging Platforms Driving Surgical Precision
15.3.11.2. Navigating Emerging Risks and Fortifying Market Leadership
15.3.12. MolecuLight Inc.
15.3.12.1. Illuminating the Rise and Reach of MolecuLight in Fluorescence Diagnostics
15.3.12.2. Deep Dive into MolecuLight’s Flagship Fluorescent Imaging Solutions
15.3.12.3. Mitigating Threats and Charting Strategic Growth for MolecuLight
15.3.13. Olympus Corporation of the Americas
15.3.13.1. Evaluating Olympus’s Pivotal Fluorescence Solutions
15.3.13.2. Mitigating Risks and Fortifying Market Leadership
15.3.14. OnLume Inc.
15.3.14.1. OnLume’s Evolution and Strategic Footprint in Fluorescence-Guided Surgery
15.3.14.2. In-Depth Evaluation of OnLume’s Flagship Fluorescence Solutions
15.3.14.3. Navigating Risks and Strategic Pathways to Fortify OnLume’s Growth
15.3.15. Optomedic.
15.3.15.1. Illuminating Optomedic.’s Flagship Fluorescence Solutions
15.3.15.2. Navigating Risks and Crafting a Resilient Growth Blueprint
15.3.16. PerkinElmer U.S. LLC
15.3.16.1. PerkinElmer’s Evolution and Impact in Fluorescence Diagnostics
15.3.16.2. Flagship Fluorescence Solutions Driving Clinical Innovation
15.3.16.3. Mitigating Threats and Seizing Strategic Opportunities
15.3.17. PicoQuant GmbH
15.3.17.1. PicoQuant’s Legacy of Precision Fluorescence Innovation
15.3.17.2. Assessing Core Fluorescence Solutions Against Medical Device Needs
15.3.17.3. Confronting Market Threats and Driving Strategic Expansion
15.3.18. Shimadzu Corporation
15.3.18.1. Pioneering Fluorescence Innovations: Shimadzu’s Evolution in Medical Devices
15.3.18.2. Flagship Fluorescence Imaging Solutions Shaping Clinical Diagnostics
15.3.18.3. Navigating Risks and Strategies to Fortify Shimadzu’s Fluorescence Portfolio
15.3.19. Stryker Corporation
15.3.19.1. Unpacking Stryker’s Flagship Fluorescence Solutions and Market Impact
15.3.19.2. Mitigating Threats and Charting Growth in Fluorescence Medical Tech
15.3.20. Xuzhou Hengjia Electronic Technology Co., Ltd.
15.3.20.1. Pioneering Fluorescence Innovation From Roots to Market Leadership
15.3.20.2. Flagship Fluorescence Solutions Powering Clinical Diagnostics Excellence
15.3.20.3. Navigating Risks and Strategic Imperatives for Future Fluorescence Dominance
15.3.21. SurgiMab SAS
15.3.21.1. Illuminating Innovations in Fluorescent Medical Devices
15.3.21.2. Navigating Risks and Charting Strategic Advances
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FLUORESCENCE IN MEDICAL DEVICE MARKET MULTI-CURRENCY
FIGURE 2. FLUORESCENCE IN MEDICAL DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. FLUORESCENCE IN MEDICAL DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FLUORESCENCE IN MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FLUORESCENCE IN MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FLUORESCENCE IN MEDICAL DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENT DYES & AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOGENOUS FLUOROPHORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY EXOGENOUS FLUOROPHORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IN CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ONCOLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOSCOPIC FLUORESCENCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-BASED OPHTHALMIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IN VIVO FLUORESCENCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 50. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 51. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 56. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 57. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 85. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 87. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 88. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 94. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 100. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 105. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 106. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 109. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 111. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 145. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 147. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 151. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 153. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 154. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 160. SWEDEN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. EGYPT FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 169. EGYPT FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. EGYPT FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 171. EGYPT FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 172. EGYPT FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. TURKEY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. TURKEY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 175. TURKEY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 177. TURKEY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. NORWAY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. NORWAY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 187. NORWAY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NORWAY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 189. NORWAY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. NORWAY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. POLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. POLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 193. POLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 195. POLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 196. POLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 202. SWITZERLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 210. CHINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. CHINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 212. CHINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. CHINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 214. CHINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 215. CHINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. INDIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. INDIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 218. INDIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. INDIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 220. INDIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. INDIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. JAPAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. JAPAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 224. JAPAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. JAPAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 226. JAPAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 227. JAPAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. THAILAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. THAILAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 248. THAILAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 250. THAILAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 251. THAILAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. FLUORESCENCE IN MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 283. FLUORESCENCE IN MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Fluorescence in Medical Device market report include:
  • ADVACAM s.r.o.
  • Arthrex, Inc.
  • Bruker Corporation
  • Carl Zeiss AG.
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • KARL STORZ SE & Co. KG
  • Leica Microsystems GmbH
  • LI-COR Biotech, LLC
  • Mauna Kea Technologies
  • Medtronic International Trading Sárl
  • MolecuLight Inc.
  • Olympus Corporation of the Americas
  • OnLume Inc.
  • Optomedic.
  • PerkinElmer U.S. LLC
  • PicoQuant GmbH
  • Shimadzu Corporation
  • Stryker Corporation
  • Xuzhou Hengjia Electronic Technology Co., Ltd.
  • SurgiMab SAS

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.28 Billion
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Fluorescence in Catheter Application Market by Product Type, Catheter Type, Light Source Technology, Dye Type, Application, End User - Global Forecast 2025-2030 - Product Image

Fluorescence in Catheter Application Market by Product Type, Catheter Type, Light Source Technology, Dye Type, Application, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Near-infrared Fluorescence Imaging Device Market by Application (Diagnostic Imaging, Research And Preclinical Imaging, Surgical Guidance), Product Type (Imaging Devices, Imaging Systems, Software And Analytics), End-User, Dye Type, Wavelength Range - Global Forecast 2025-2030 - Product Image

Near-infrared Fluorescence Imaging Device Market by Application (Diagnostic Imaging, Research And Preclinical Imaging, Surgical Guidance), Product Type (Imaging Devices, Imaging Systems, Software And Analytics), End-User, Dye Type, Wavelength Range - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Indocyanine Green Market by Application (Cancer Detection, Cardiac Output Measurement, Fluorescence Imaging), End User (Ambulatory Surgical Centers, Hospitals, Research Institutes), Product Type - Global Forecast 2025-2030 - Product Image

Indocyanine Green Market by Application (Cancer Detection, Cardiac Output Measurement, Fluorescence Imaging), End User (Ambulatory Surgical Centers, Hospitals, Research Institutes), Product Type - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
HD Fluorescence Endoscope Light Source Module Market by Technology (Laser, Led, Xenon Lamp), Application (Arthroscopy, Bronchoscopy, Ent Endoscopy), End User, Wavelength Range, Distribution Channel - Global Forecast 2025-2030 - Product Image

HD Fluorescence Endoscope Light Source Module Market by Technology (Laser, Led, Xenon Lamp), Application (Arthroscopy, Bronchoscopy, Ent Endoscopy), End User, Wavelength Range, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Fluorescent Filter Cube Market by Filter Type (Dichroic, Emission, Excitation), Application (Clinical Diagnostics, Education, Industrial Inspection), Fluorophore Compatibility, Material, Configuration, Sales Channel, Price Range - Global Forecast 2025-2030 - Product Image

Fluorescent Filter Cube Market by Filter Type (Dichroic, Emission, Excitation), Application (Clinical Diagnostics, Education, Industrial Inspection), Fluorophore Compatibility, Material, Configuration, Sales Channel, Price Range - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.